Ironwood Pharmaceuticals, Inc. (IRWD) free cash flow

Free cash flow · fiscal 2025
$127.01M

Ironwood Pharmaceuticals, Inc. (IRWD) generated free cash flow of $127.01M in fiscal 2025 (the year ended December 31, 2025). That is 22.8% higher than the $103.41M of fiscal 2024. Figures as of 18 Nov 2026, 11:38 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
$127.01M
Change on fiscal 2024
+22.8%
Growth, 5 years
−5.3% a year
Highest on record
$273.63Mfiscal 2022
Lowest on record
-$282.95Mfiscal 2013
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Ironwood Pharmaceuticals, Inc. free cash flow, in more detail

Over the five fiscal years to 2025 free cash flow shrank at a compound 5.3% a year. Across the 17 fiscal years on record (2009–2025), the highest was $273.63M in fiscal 2022 and the lowest -$282.95M in fiscal 2013.

History · 17 fiscal years

Free cash flow by fiscal year

Ironwood Pharmaceuticals, Inc. free cash flow, year by year

Ironwood Pharmaceuticals, Inc. (IRWD) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025$127.01M 22.8% up
2024$103.41M 43.5% down
2023$183.15M 33.1% down
2022$273.63M 4.6% up
2021$261.63M 56.7% up
2020$166.99M 4,622.7% up
2019$3.54M—
2018-$71.23M—
2017-$103.56M—
2016-$30.14M—
2015-$110.98M—
2014-$159.11M—
2013-$282.95M—
2012-$83.61M—
2011-$84.92M—
2010-$85.12M—
2009-$6.97M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

More on IRWD

Ironwood Pharmaceuticals, Inc., figure by figure

Ironwood Pharmaceuticals, Inc. (IRWD) overview: price, valuation and scorecard

Ironwood Pharmaceuticals, Inc. free cash flow: questions and answers

What is Ironwood Pharmaceuticals, Inc.'s free cash flow?

Ironwood Pharmaceuticals, Inc. (IRWD) generated free cash flow of $127.01M in fiscal 2025 (the year ended December 31, 2025). That is 22.8% higher than the $103.41M of fiscal 2024.

What is the growth rate of Ironwood Pharmaceuticals, Inc.'s free cash flow?

Over the five fiscal years to 2025 free cash flow shrank at a compound 5.3% a year.

What are the highest and lowest free cash flow figures on record for Ironwood Pharmaceuticals, Inc.?

Across the 17 fiscal years on record (2009–2025), the highest was $273.63M in fiscal 2022 and the lowest -$282.95M in fiscal 2013.

How is Ironwood Pharmaceuticals, Inc.'s free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Ironwood Pharmaceuticals, Inc. it is on record here for 17 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Ironwood Pharmaceuticals, Inc. (IRWD) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/IRWD/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.